LI, Yongtao. FDA Regulatory Milestones, Announcement Framing, and Biotechnology Stock Returns: Evidence on the Feasibility of an AI-Native Comparison, 2019-2026. Highlights in Business, Economics and Management, [S. l.], v. 70, p. 94–102, 2026. DOI: 10.54097/n6naqe96. Disponível em: https://hbemdata.com/index.php/ojs/article/view/22. Acesso em: 23 oct. 2026.